COVID-19 has been declared a pandemic by the World Health Organization on March 11, and since then, more than 3 million cases and a quarter million deaths have occurred due to it. Lately, there is a growing evidence for an ophthalmologic symptom (conjunctivitis) to be connected with the disease. This seems to happen in early stages of the infection by SARS-CoV-2, and thus, it is of major importance to understand the mechanism through which the virus can facilitate such a symptom. Here, we are proposing a molecular mechanism through which the novel coronavirus could act in order to affect the eye and use it as another, secondary but alternative, point of entry to the host organism.
Keywords: ACE2; COVID-19; Conjunctivitis; ECM proteins; HSPG; Molecular ophthalmology; Ophthalmology; Pandemic; Picornavirus; Pink eye; SARS-CoV-2.
© Springer Nature Switzerland AG 2020.